Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Clinical trial NCT04552288 · COMPLETED

Trial details

NCT number: NCT04552288
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Solid Carcinoma Solid Tumor, Adult Hematologic Malignancy

Start date: 2020-09-16
Primary completion: 2024-07-19
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.